{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:17:46Z","timestamp":1791278266685,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.biocel.2005.12.009","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T15:23:45Z","timestamp":1137597825000},"page":"726-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Role of islet amyloid in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"38","author":[{"given":"Jo W.M.","family":"H\u00f6ppener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees J.M.","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2005.12.009_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1566524053766004","article-title":"Type 2 diabetes, insulin secretion and beta-cell mass","volume":"5","author":"Ahr\u00e9n","year":"2005","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506120309041728","article-title":"Amyloidogenesis: Historical and modern observations point to heparin sulfate proteoglycans as a major culprit","volume":"10","author":"Ancsin","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.biocel.2005.12.009_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1464-5491.2005.01550.x","article-title":"Genetics of type 2 diabetes","volume":"22","author":"Barroso","year":"2005","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","article-title":"Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains difference in islet amyloid formation between species","volume":"251","author":"Betsholtz","year":"1989","journal-title":"FEBS Letters"},{"key":"10.1016\/j.biocel.2005.12.009_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2005.12.009_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2005.12.009_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00125-004-1379-6","article-title":"Glucagon-like peptide-1 prevents beta cell glucolipotoxicity","volume":"47","author":"Buteau","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.biocel.2005.12.009_bib8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","article-title":"Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat)","volume":"53","author":"Butler","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib10","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased \u03b2-cell apoptosis prevents adaptive increase in \u03b2-cell mass in mouse model of type 2 diabetes. Evidence for role of islet amyloid formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annual Reviews in Neurosciences"},{"key":"10.1016\/j.biocel.2005.12.009_bib12","first-page":"1","article-title":"The regulation of amylin and insulin gene expression and secretion","volume":"30","author":"Cluck","year":"2005","journal-title":"Pancreas"},{"issue":"Suppl. 2","key":"10.1016\/j.biocel.2005.12.009_bib13","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib14","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00024677-200201040-00001","article-title":"Impaired glucose tolerance: Is there a case for pharmacologic intervention?","volume":"1","author":"Costa","year":"2002","journal-title":"Treatments in Endocrinology"},{"key":"10.1016\/j.biocel.2005.12.009_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00402271","article-title":"Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population","volume":"36","author":"De Koning","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.biocel.2005.12.009_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","article-title":"Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"15","author":"Enoki","year":"1992","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.biocel.2005.12.009_bib18","first-page":"1777","article-title":"The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes","volume":"12","author":"German","year":"1992","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.biocel.2005.12.009_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2141.1997.303194.x","article-title":"Amyloidosis: A review of recent diagnostic and therapeutic developments","volume":"99","author":"Gillmore","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.biocel.2005.12.009_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","article-title":"Amyloid deposits and amyloidosis: The \u03b2-fibrilloses","volume":"302","author":"Glenner","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0006-3495(04)74119-3","article-title":"Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel","volume":"86","author":"Gordon","year":"2004","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.biocel.2005.12.009_bib22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0026-0495(97)90209-2","article-title":"Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents","volume":"46","author":"Gulli","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.biocel.2005.12.009_bib23","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1046\/j.1432-1327.2000.01548.x","article-title":"Processing of synthetic pro-islet amyloid polypeptide (proIAPP) \u2018amylin\u2019 by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro","volume":"267","author":"Higham","year":"2000","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib24","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0002-9440(10)64852-3","article-title":"A feline model of experimentally induced islet amyloidosis","volume":"157","author":"Hoenig","year":"2000","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.biocel.2005.12.009_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0303-7207(02)00266-6","article-title":"Role of islet amyloid in type 2 diabetes mellitus: Consequence or cause?","volume":"197","author":"H\u00f6ppener","year":"2002","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.biocel.2005.12.009_bib27","first-page":"1995","article-title":"Eilandjesamyloid en diabetes mellitus type 2","volume":"42","author":"H\u00f6ppener","year":"2000","journal-title":"Nederlands Tijdschrift voor de Geneeskunde"},{"key":"10.1016\/j.biocel.2005.12.009_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001250051175","article-title":"Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a transgenic mouse model","volume":"42","author":"H\u00f6ppener","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.biocel.2005.12.009_bib29","unstructured":"H\u00f6ppener, J.W.M., Oosterwijk, C., Wierup, N., Jacobs, H.M., Nieuwenhuis, M.G., Lips, C.J.M., et al. Islet amyloid and glucose intolerance in high-fat fed mice transgenic for human islet amyloid polypeptide, unpublished results."},{"key":"10.1016\/j.biocel.2005.12.009_bib30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/BF00400803","article-title":"Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia","volume":"36","author":"H\u00f6ppener","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.biocel.2005.12.009_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","article-title":"Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid","volume":"52","author":"Hull","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib32","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2337\/diabetes.54.7.2235","article-title":"Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide","volume":"54","author":"Hull","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/bbrc.1999.1989","article-title":"Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines","volume":"267","author":"Janciauskiene","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.biocel.2005.12.009_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib35","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A\u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2005.12.009_bib37","doi-asserted-by":"crossref","first-page":"48420","DOI":"10.1074\/jbc.M406853200","article-title":"Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling","volume":"279","author":"Jayasinghe","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0006-291X(90)90359-U","article-title":"Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes","volume":"169","author":"Jordan","year":"1990","journal-title":"Biochemical Biophysical Research Communications"},{"key":"10.1016\/j.biocel.2005.12.009_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81125-3","article-title":"Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance","volume":"92","author":"Kahn","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2005.12.009_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/JPEM.2003.16.1.5","article-title":"Glucotoxicity and beta-cell failure in type 2 diabetes mellitus","volume":"16","author":"Kaiser","year":"2003","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2005.12.009_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biocel.2005.12.009_bib42","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/JBCPP.1998.9.2-4.325","article-title":"Genetic models for non insulin dependent diabetes mellitus in rodents","volume":"9","author":"Kim","year":"1998","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"key":"10.1016\/j.biocel.2005.12.009_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1385\/JMN:20:3:291","article-title":"Novel glycosaminoglycan precursors as anti-amyloid agents. Part III","volume":"20","author":"Kisilevsky","year":"2003","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.biocel.2005.12.009_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/BF00400660","article-title":"Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance","volume":"9","author":"Larsson","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.biocel.2005.12.009_bib46","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.86.9.3127","article-title":"Rat amylin: Cloning and tissue-specific expression in pancreatic islets","volume":"86","author":"Leffert","year":"1989","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"Suppl. 4","key":"10.1016\/j.biocel.2005.12.009_bib47","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/sj.ijo.0802854","article-title":"Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation","volume":"28","author":"Lelliot","year":"2004","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.biocel.2005.12.009_bib48","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.biocel.2004.04.016","article-title":"Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: From apoptosis to autophagy","volume":"36","author":"Liberski","year":"2004","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2005.12.009_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.biocel.2005.12.009_bib50","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S9::AID-DIA397>3.0.CO;2-D","article-title":"Amylin: History and overview","volume":"14","author":"Ludvik","year":"1997","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib51","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1210\/me.2004-0407","article-title":"Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells","volume":"19","author":"Marzban","year":"2005","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.biocel.2005.12.009_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of beta-cell prohormone convertase (PC) 1\/3 in processing of pro-islet amyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib53","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","article-title":"Pore formation by the cytotoxic islet amyloid peptide amylin","volume":"271","author":"Mirzabekov","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A\u03b2 peptide vaccination prevents memory loss in an animal model of Alzheimer's disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2005.12.009_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(88)80922-0","article-title":"Islet amyloid polypeptide: Identification and chromosomal localization of the human gene","volume":"239","author":"Mosselman","year":"1988","journal-title":"FEBS Letters"},{"key":"10.1016\/j.biocel.2005.12.009_bib56","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.94.25.13921","article-title":"Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin","volume":"94","author":"Murphy","year":"1997","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib57","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1073\/pnas.86.15.5738","article-title":"Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone","volume":"86","author":"Nishi","year":"1989","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0303-7207(02)00265-4","article-title":"Pathogenesis of feline diabetes mellitus","volume":"197","author":"O\u2019Brien","year":"2002","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.biocel.2005.12.009_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/030098589603300501","article-title":"Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): An animal model of human non-insulin-dependent diabetes mellitus","volume":"33","author":"O\u2019Brien","year":"1996","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.biocel.2005.12.009_bib60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/030098589002700307","article-title":"Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors","volume":"27","author":"O\u2019Brien","year":"1990","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.biocel.2005.12.009_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of langerhans","volume":"5","author":"Opie","year":"1901","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.283.5398.36","article-title":"Effects of medical research on health care and economy","volume":"283","author":"Pardes","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biocel.2005.12.009_bib63","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","article-title":"Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation","volume":"276","author":"Park","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib64","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/417254a","article-title":"Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis","volume":"417","author":"Pepys","year":"2002","journal-title":"Nature"},{"issue":"Suppl. 3","key":"10.1016\/j.biocel.2005.12.009_bib66","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.2337\/diabetes.51.2007.S405","article-title":"Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: Role in beta-cell adaptation and failure in the etiology of diabetes","volume":"51","author":"Prentki","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1098-612X(99)90203-6","article-title":"Current understanding of feline diabetes. Part 1. Pathogenesis","volume":"1","author":"Rand","year":"1999","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.biocel.2005.12.009_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type 2 diabetes\u2014a matter of \u03b2-cell life and death","volume":"307","author":"Rhodes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biocel.2005.12.009_bib69","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1002\/1521-3765(20020916)8:18<4285::AID-CHEM4285>3.0.CO;2-0","article-title":"Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides","volume":"8","author":"Rijkers","year":"2002","journal-title":"Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib70","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"Robertson","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib71","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/clinchem\/48.12.2270","article-title":"Insulin: Discovery and controversy","volume":"48","author":"Rosenfeld","year":"2002","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib72","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1038\/oby.2004.273","article-title":"The obesity pandemic: Where have we been and where are we going?","volume":"12","author":"Roth","year":"2004","journal-title":"Obesity Research"},{"key":"10.1016\/j.biocel.2005.12.009_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1078\/0065-1281-00718","article-title":"Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors","volume":"105","author":"Rotondo","year":"2003","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.biocel.2005.12.009_bib74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00041433-200306000-00008","article-title":"Lipotoxicity: When tissues overeat","volume":"14","author":"Schaffer","year":"2003","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.biocel.2005.12.009_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Towards a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.biocel.2005.12.009_bib76","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.47.5.743","article-title":"Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide","volume":"47","author":"Soeller","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib77","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2337\/diacare.28.11.2626","article-title":"The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature","volume":"28","author":"Sorkin","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biocel.2005.12.009_bib78","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: Principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2005.12.009_bib79","first-page":"637","article-title":"An underdiagnosed type of diabetes: The MODY syndromes. Pathophysiology, clinical presentation and renal disease progression","volume":"17","author":"Tsakiris","year":"2004","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.biocel.2005.12.009_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/eje.0.1400069","article-title":"Islet amyloid polypeptide (IAPP)\/amylin messenger RNA and protein expression in human insulinomas: Relation to amyloid formation","volume":"140","author":"Van Hulst","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.biocel.2005.12.009_bib81","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib82","first-page":"135","article-title":"\u00dcber eine im Gehirn und R\u00fcckenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose","volume":"6","author":"Virchow","year":"1854","journal-title":"Archives of Pathological Anatomy and Physiology and Clinical Medicine"},{"key":"10.1016\/j.biocel.2005.12.009_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/019262301301418955","article-title":"Naturally occurring and experimental diabetes in cynomolgus monkeys: A comparison of carbohydrate and lipid metabolism and islet pathology","volume":"29","author":"Wagner","year":"2001","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.biocel.2005.12.009_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200565010-00001","article-title":"Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus","volume":"65","author":"Walter","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.biocel.2005.12.009_bib85","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/13506129409148624","article-title":"Amyloid and polypeptide hormones: What is their relationship?","volume":"1","author":"Westermark","year":"1994","journal-title":"Amyloid: The International Journal of Experimental and Clinical Investigation"},{"key":"10.1016\/j.biocel.2005.12.009_bib87","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib88","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1517\/03009734000000057","article-title":"Pro islet amyloid polypeptide (ProIAPP) immunoreactivity in the islets of Langerhans","volume":"105","author":"Westermark","year":"2000","journal-title":"Upsala Journal of Medical Sciences"},{"key":"10.1016\/j.biocel.2005.12.009_bib89","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.biocel.2005.12.009_bib90","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibrilprotein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochemical Biophysical Research Communications"},{"key":"10.1016\/j.biocel.2005.12.009_bib91","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2005.12.009_bib92","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biocel.2005.12.009_bib93","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1753-4887.2004.tb00009.x","article-title":"Insulin resistance and obesity: Resistin, a hormone secreted by adipose tissue","volume":"62","author":"Wolf","year":"2004","journal-title":"Nutrition Reviews"},{"key":"10.1016\/j.biocel.2005.12.009_bib94","doi-asserted-by":"crossref","first-page":"52810","DOI":"10.1074\/jbc.M308244200","article-title":"Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1","volume":"278","author":"Zhang","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2005.12.009_bib95","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/diabetes.52.11.2759","article-title":"Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes","volume":"52","author":"Zhao","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.biocel.2005.12.009_bib96","doi-asserted-by":"crossref","first-page":"6S9","DOI":"10.1016\/S1262-3636(03)72783-9","article-title":"The burden of type 2 diabetes: Are we doing enough?","volume":"29","author":"Zimmet","year":"2003","journal-title":"Diabetes and Metabolism"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272505004139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272505004139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:26:08Z","timestamp":1761200768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272505004139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":96,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1357272505004139"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2005.12.009","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of islet amyloid in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2005.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}